Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


26.11.2018

3 Ann Surg Oncol
3 BMC Cancer
3 Breast Cancer
8 Breast Cancer Res
11 Breast Cancer Res Treat
2 Breast J
1 Cancer Chemother Pharmacol
1 Clin Breast Cancer
1 Int J Cancer
1 Int J Radiat Oncol Biol Phys
2 J Biol Chem
1 J Clin Oncol
2 J Natl Cancer Inst
4 J Surg Oncol
1 Nature
2 NPJ Breast Cancer
4 Oncogene
2 Oncol Rep
4 PLoS One
1 Radiology
3 Radiother Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg Oncol

  1. SHARMA R
    ASO Author Reflections: Eighty is the New Sixty-Breast Cancer Treatment Strategies in the Octogenarian Patient Population.
    Ann Surg Oncol. 2018 Nov 21. pii: 10.1245/s10434-018-7071.
    PubMed     Text format    

  2. VAN LOEVEZIJN AA, Bartels SAL, van Duijnhoven FH, Heemsbergen WD, et al
    Internal Mammary Chain Sentinel Nodes in Early-Stage Breast Cancer Patients: Toward Selective Removal.
    Ann Surg Oncol. 2018 Nov 21. pii: 10.1245/s10434-018-7058.
    PubMed     Text format     Abstract available

  3. WANG M, Wu K, Zhang P, Zhang M, et al
    The Prognostic Significance of the Oncotype DX Recurrence Score in T1-2N1M0 Estrogen Receptor-Positive HER2-Negative Breast Cancer Based on the Prognostic Stage in the Updated AJCC 8th Edition.
    Ann Surg Oncol. 2018 Nov 19. pii: 10.1245/s10434-018-7068.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. VAN OMMEN-NIJHOF A, Konings IR, van Zeijl CJJ, Uyl-de Groot CA, et al
    Selecting the optimal position of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer - the SONIA study: study protocol for a randomized controlled trial.
    BMC Cancer. 2018;18:1146.
    PubMed     Text format     Abstract available

  5. GOTO W, Kashiwagi S, Asano Y, Takada K, et al
    Predictive value of lymphocyte-to-monocyte ratio in the preoperative setting for progression of patients with breast cancer.
    BMC Cancer. 2018;18:1137.
    PubMed     Text format     Abstract available

  6. JIN B, Zhang S, Chuang X, Yu P, et al
    Breast cancer and synchronous multiple primary lung adenocarcinomas with heterogeneous mutations: a case report.
    BMC Cancer. 2018;18:1138.
    PubMed     Text format     Abstract available


    Breast Cancer

  7. KANAYA N, Tanakaya K, Yamasaki R, Arata T, et al
    Clinicopathological features of breast cancer in Japanese female patients with Lynch syndrome.
    Breast Cancer. 2018 Nov 16. pii: 10.1007/s12282-018-0931.
    PubMed     Text format     Abstract available

  8. WANG R, Li J, Yin C, Zhao D, et al
    Identification of differentially expressed genes and typical fusion genes associated with three subtypes of breast cancer.
    Breast Cancer. 2018 Nov 16. pii: 10.1007/s12282-018-0924.
    PubMed     Text format     Abstract available

  9. GORCZYNSKI RM, Erin N, Maqbool T, Gorczynski CP, et al
    Characterization of an in vitro model system to explore control of tumor invasion of EMT6 and 4THM breast tumors by CD200:CD200R interactions.
    Breast Cancer. 2018;25:547-559.
    PubMed     Text format     Abstract available


    Breast Cancer Res

  10. FRISK G, Ekberg S, Lidbrink E, Eloranta S, et al
    No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study.
    Breast Cancer Res. 2018;20:142.
    PubMed     Text format     Abstract available

  11. VETTER M, Landin J, Szczerba BM, Castro-Giner F, et al
    Denosumab treatment is associated with the absence of circulating tumor cells in patients with breast cancer.
    Breast Cancer Res. 2018;20:141.
    PubMed     Text format     Abstract available

  12. VAN DER WILLIK KD, Koppelmans V, Hauptmann M, Compter A, et al
    Inflammation markers and cognitive performance in breast cancer survivors 20 years after completion of chemotherapy: a cohort study.
    Breast Cancer Res. 2018;20:135.
    PubMed     Text format     Abstract available

  13. RHOST S, Hughes E, Harrison H, Rafnsdottir S, et al
    Sortilin inhibition limits secretion-induced progranulin-dependent breast cancer progression and cancer stem cell expansion.
    Breast Cancer Res. 2018;20:137.
    PubMed     Text format     Abstract available

  14. BECKWITT CH, Brufsky A, Oltvai ZN, Wells A, et al
    Statin drugs to reduce breast cancer recurrence and mortality.
    Breast Cancer Res. 2018;20:144.
    PubMed     Text format     Abstract available

  15. LEECH AO, Vellanki SH, Rutherford EJ, Keogh A, et al
    Cleavage of the extracellular domain of junctional adhesion molecule-A is associated with resistance to anti-HER2 therapies in breast cancer settings.
    Breast Cancer Res. 2018;20:140.
    PubMed     Text format     Abstract available

  16. CHATTERJEE G, Pai T, Hardiman T, Avery-Kiejda K, et al
    Molecular patterns of cancer colonisation in lymph nodes of breast cancer patients.
    Breast Cancer Res. 2018;20:143.
    PubMed     Text format     Abstract available

  17. WEGE AK, Chittka D, Buchholz S, Klinkhammer-Schalke M, et al
    HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women.
    Breast Cancer Res. 2018;20:139.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  18. XU R, Tang P, Li C
    Association between pre-operative magnetic resonance imaging (MRI) and surgical outcomes in breast cancer: not yet determined.
    Breast Cancer Res Treat. 2018 Nov 16. pii: 10.1007/s10549-018-5010.
    PubMed     Text format    

  19. LIU J, Liu L, Yague E, Yang Q, et al
    GGNBP2 suppresses triple-negative breast cancer aggressiveness through inhibition of IL-6/STAT3 signaling activation.
    Breast Cancer Res Treat. 2018 Nov 19. pii: 10.1007/s10549-018-5052.
    PubMed     Text format     Abstract available

  20. LEE KWC, Lord S, Finn RS, Lim E, et al
    The impact of ethnicity on efficacy and toxicity of cyclin D kinase 4/6 inhibitors in advanced breast cancer: a meta-analysis.
    Breast Cancer Res Treat. 2018 Nov 21. pii: 10.1007/s10549-018-5054.
    PubMed     Text format     Abstract available

  21. CAO J, Eshak ES, Liu K, Muraki I, et al
    Sleep duration and risk of breast cancer: The JACC Study.
    Breast Cancer Res Treat. 2018 Nov 20. pii: 10.1007/s10549-018-4995.
    PubMed     Text format     Abstract available

  22. JONGEN L, Floris G, Boeckx B, Smeets D, et al
    Identification, clinical-pathological characteristics and treatment outcomes of patients with metastatic breast cancer and somatic human epidermal growth factor receptor 2 (ERBB2) mutations.
    Breast Cancer Res Treat. 2018 Nov 19. pii: 10.1007/s10549-018-5049.
    PubMed     Text format     Abstract available

  23. CAPARICA R, Bruzzone M, Poggio F, Ceppi M, et al
    Anthracycline and taxane-based chemotherapy versus docetaxel and cyclophosphamide in the adjuvant treatment of HER2-negative breast cancer patients: a systematic review and meta-analysis of randomized controlled trials.
    Breast Cancer Res Treat. 2018 Nov 21. pii: 10.1007/s10549-018-5055.
    PubMed     Text format     Abstract available

  24. CORSO G, Pravettoni G, Galimberti V, Veronesi P, et al
    Clinical implication of E-cadherin deficiency in lobular breast cancer.
    Breast Cancer Res Treat. 2018 Nov 17. pii: 10.1007/s10549-018-5051.
    PubMed     Text format    

  25. ZOOROB RJ, Salemi JL, Mejia de Grubb MC, Modak S, et al
    A nationwide study of breast cancer, depression, and multimorbidity among hospitalized women and men in the United States.
    Breast Cancer Res Treat. 2018 Nov 21. pii: 10.1007/s10549-018-5059.
    PubMed     Text format     Abstract available

  26. BLEICHER RJ, Chang C, Wang CE, Goldstein LJ, et al
    Treatment delays from transfers of care and their impact on breast cancer quality measures.
    Breast Cancer Res Treat. 2018 Nov 15. pii: 10.1007/s10549-018-5046.
    PubMed     Text format     Abstract available

  27. HASKINS CB, McDowell BD, Carnahan RM, Fiedorowicz JG, et al
    Impact of preexisting mental illness on breast cancer endocrine therapy adherence.
    Breast Cancer Res Treat. 2018 Nov 21. pii: 10.1007/s10549-018-5050.
    PubMed     Text format     Abstract available

  28. DIBABA DT, Ogunsina K, Braithwaite D, Akinyemiju T, et al
    Metabolic syndrome and risk of breast cancer mortality by menopause, obesity, and subtype.
    Breast Cancer Res Treat. 2018 Nov 21. pii: 10.1007/s10549-018-5056.
    PubMed     Text format     Abstract available


    Breast J

  29. GUVENC I, Whitman GJ, Liu P, Yalniz C, et al
    Diffusion-weighted MR imaging increases diagnostic accuracy of breast MR imaging for predicting axillary metastases in breast cancer patients.
    Breast J. 2018 Nov 16. doi: 10.1111/tbj.13151.
    PubMed     Text format     Abstract available

  30. HUNTER-SQUIRES J, Giuliano AE
    Biopsy of abnormal intramammary and axillary lymph nodes in patients without breast cancer.
    Breast J. 2018;24:867-868.
    PubMed     Text format    


    Cancer Chemother Pharmacol

  31. CAZZANIGA ME, Ciruelos E, Fabi A, Garcia-Saenz J, et al
    Metastatic or locally advanced breast cancer patients: towards an expert consensus on nab-paclitaxel treatment in HER2-negative tumours-the MACBETH project.
    Cancer Chemother Pharmacol. 2018 Nov 20. pii: 10.1007/s00280-018-3717.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  32. PASSILDAS J, Collard O, Savoye AM, Dohou J, et al
    Impact of Chemotherapy-induced Menopause in Women of Childbearing Age With Non-metastatic Breast Cancer - Preliminary Results From the MENOCOR Study.
    Clin Breast Cancer. 2018 Oct 23. pii: S1526-8209(18)30373.
    PubMed     Text format     Abstract available


    Int J Cancer

  33. PEREIRA-VEIGA T, Abreu M, Robledo D, Matias-Guiu X, et al
    CTCs-derived xenograft development in a Triple Negative breast cancer case.
    Int J Cancer. 2018 Nov 19. doi: 10.1002/ijc.32001.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  34. DEMISSEI BG, Freedman G, Feigenberg SJ, Plastaras JP, et al
    Early changes in cardiovascular biomarkers with contemporary thoracic radiation therapy for breast cancer, lung cancer and lymphoma.
    Int J Radiat Oncol Biol Phys. 2018 Nov 13. pii: S0360-3016(18)33999.
    PubMed     Text format     Abstract available


    J Biol Chem

  35. LI Z, Lim SK, Liang X, Lim YP, et al
    The transcriptional coactivator WBP2 primes triple-negative breast cancer cells for responses to Wnt signaling via the JNK/Jun kinase pathway.
    J Biol Chem. 2018 Nov 15. pii: RA118.005796. doi: 10.1074/jbc.RA118.005796.
    PubMed     Text format     Abstract available

  36. JEONG J, Choi J, Kim W, Dann P, et al
    Inhibition of ezrin causes PKCalpha-mediated internalization of erbb2/HER2 tyrosine kinase in breast cancer cells.
    J Biol Chem. 2018 Nov 21. pii: RA118.004143. doi: 10.1074/jbc.RA118.004143.
    PubMed     Text format     Abstract available


    J Clin Oncol

  37. BURSTEIN HJ, Lacchetti C, Anderson H, Buchholz TA, et al
    Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update.
    J Clin Oncol. 2018 Nov 19:JCO1801160. doi: 10.1200/JCO.18.01160.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  38. KENSLER KH, Poole EM, Heng YJ, Collins LC, et al
    Androgen Receptor Expression and Breast Cancer Survival: Results From the Nurses' Health Studies.
    J Natl Cancer Inst. 2018 Nov 15. pii: 5184399. doi: 10.1093.
    PubMed     Text format     Abstract available

  39. HATEM E, Azzi S, El Banna N, He T, et al
    Auranofin/Vitamin C: A Novel Drug Combination Targeting Triple-Negative Breast Cancer.
    J Natl Cancer Inst. 2018 Nov 20. pii: 5193772. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Surg Oncol

  40. MAY M, Chin C, Hirji S, Horowitz D, et al
    Comparing preoperative imaging modalities in patient selection for breast intraoperative radiotherapy.
    J Surg Oncol. 2018;118:959-965.
    PubMed     Text format     Abstract available

  41. OLASEHINDE O, Alatise O, Arowolo O, Adisa A, et al
    Safety and feasibility of early postmastectomy discharge and home drain care in a low resource setting.
    J Surg Oncol. 2018;118:861-866.
    PubMed     Text format     Abstract available

  42. YU TJ, Liu YY, Hu X, Di GH, et al
    No survival improvement of contralateral prophylactic mastectomy among women with invasive lobular carcinoma.
    J Surg Oncol. 2018;118:928-935.
    PubMed     Text format     Abstract available

  43. XU F, Sun H, Zhang C, Jiang H, et al
    Comparison of surgical complication between immediate implant and autologous breast reconstruction after mastectomy: A multicenter study of 426 cases.
    J Surg Oncol. 2018;118:953-958.
    PubMed     Text format     Abstract available


    Nature

  44. CHEN J, Ou Y, Yang Y, Li W, et al
    KLHL22 activates amino-acid-dependent mTORC1 signalling to promote tumorigenesis and ageing.
    Nature. 2018;557:585-589.
    PubMed     Text format     Abstract available


    NPJ Breast Cancer

  45. GEYER CE JR, Tang G, Mamounas EP, Rastogi P, et al
    21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer.
    NPJ Breast Cancer. 2018;4:37.
    PubMed     Text format     Abstract available

  46. FAHAM N, Zhao L, Welm AL
    mTORC1 is a key mediator of RON-dependent breast cancer metastasis with therapeutic potential.
    NPJ Breast Cancer. 2018;4:36.
    PubMed     Text format     Abstract available


    Oncogene

  47. KUMAR S, Srivastav RK, Wilkes DW, Ross T, et al
    Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer.
    Oncogene. 2018 Nov 15. pii: 10.1038/s41388-018-0562.
    PubMed     Text format     Abstract available

  48. TORRES-ADORNO AM, Vitrac H, Qi Y, Tan L, et al
    Eicosapentaenoic acid in combination with EPHA2 inhibition shows efficacy in preclinical models of triple-negative breast cancer by disrupting cellular cholesterol efflux.
    Oncogene. 2018 Nov 20. pii: 10.1038/s41388-018-0569.
    PubMed     Text format     Abstract available

  49. AN J, Du Y, Fan X, Wang Y, et al
    EGFL6 promotes breast cancer by simultaneously enhancing cancer cell metastasis and stimulating tumor angiogenesis.
    Oncogene. 2018 Nov 19. pii: 10.1038/s41388-018-0565.
    PubMed     Text format     Abstract available

  50. ZHAO Z, Hao D, Wang L, Li J, et al
    CtBP promotes metastasis of breast cancer through repressing cholesterol and activating TGF-beta signaling.
    Oncogene. 2018 Nov 15. pii: 10.1038/s41388-018-0570.
    PubMed     Text format     Abstract available


    Oncol Rep

  51. SUN X, Zhang H, Zhang Y, Yang Q, et al
    Caspase-dependent mitochondrial apoptotic pathway is involved in astilbin-mediated cytotoxicity in breast carcinoma cells.
    Oncol Rep. 2018;40:2278-2286.
    PubMed     Text format     Abstract available

  52. LIAO S, Gan L, Qin W, Liu C, et al
    Inhibition of GSK3 and MEK induced cancer stem cell generation via the Wnt and MEK signaling pathways.
    Oncol Rep. 2018;40:2005-2013.
    PubMed     Text format     Abstract available


    PLoS One

  53. MBOGE MY, Chen Z, Wolff A, Mathias JV, et al
    Selective inhibition of carbonic anhydrase IX over carbonic anhydrase XII in breast cancer cells using benzene sulfonamides: Disconnect between activity and growth inhibition.
    PLoS One. 2018;13:e0207417.
    PubMed     Text format     Abstract available

  54. ALSHAREEDA AT, Rakha E, Alghwainem A, Alrfaei B, et al
    The effect of human placental chorionic villi derived mesenchymal stem cell on triple-negative breast cancer hallmarks.
    PLoS One. 2018;13:e0207593.
    PubMed     Text format     Abstract available

  55. KWON MJ, Lee SB, Han J, Lee JE, et al
    BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer.
    PLoS One. 2018;13:e0207155.
    PubMed     Text format     Abstract available

  56. CAMPOS-RODRIGUEZ F, Cruz-Medina A, Selma MJ, Rodriguez-de-la-Borbolla-Artacho M, et al
    Association between sleep-disordered breathing and breast cancer aggressiveness.
    PLoS One. 2018;13:e0207591.
    PubMed     Text format     Abstract available


    Radiology

  57. RODRIGUEZ-RUIZ A, Krupinski E, Mordang JJ, Schilling K, et al
    Detection of Breast Cancer with Mammography: Effect of an Artificial Intelligence Support System.
    Radiology. 2018 Nov 20:181371. doi: 10.1148/radiol.2018181371.
    PubMed     Text format     Abstract available


    Radiother Oncol

  58. WANG W, Ward R, Jia D, Ashworth S, et al
    Location of arm draining lymph node in relation to breast cancer radiotherapy field and target volume.
    Radiother Oncol. 2018 Nov 13. pii: S0167-8140(18)33579.
    PubMed     Text format     Abstract available

  59. TANG S, Otton J, Holloway L, Delaney GP, et al
    Quantification of cardiac subvolume dosimetry using a 17 segment model of the left ventricle in breast cancer patients receiving tangential beam radiotherapy.
    Radiother Oncol. 2018 Nov 13. pii: S0167-8140(18)33505.
    PubMed     Text format     Abstract available

  60. MANCOSU P, Nicolini G, Goretti G, De Rose F, et al
    Applying Lean-Six-Sigma Methodology in radiotherapy: Lessons learned by the breast daily repositioning case.
    Radiother Oncol. 2018;127:326-331.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: